Addressing Biosecurity Barriers in High-Risk Biological Research

Read full text
Authors: David R. Gillum, Randy A. Albrecht, Rebecca Caruso, Amanda Craigen, Lesley Decker, Haley L. DeMers, Colleen Driskill, Robert Foreman, Deborah Howard, Barbara Johnson, Jens H. Kuhn, Yong-Bee Lim
+12 more Rebecca L. Moritz, Corrie Ntiforo, Luis Alberto Ochoa Carrera, Gregory Park, Christina L. Pier, Antony Schwartz, Adrian Self, Megan Shoff, Paul Skoglund, Mary Turlington-Powell, H WANG, Kathleen M. Vogel
Cited by: 1
References: 18

Abstract

Biological research, including dual-use research of concern and pathogens with enhanced pandemic potential, faces mounting regulatory scrutiny that may impact pandemic preparedness and scientific progress. At a 2024 deliberative workshop in Reno, Nevada, biosafety professionals, biosecurity experts, and life sciences researchers discussed potential barriers to effective governance, including ambiguous regulatory definitions, resource disparities between regulated institutions, and fragmented oversight frameworks that impose burdens without improving safety or security. By incorporating biosafety professionals' expertise into policymaking, fostering a collaborative dialogue over punitive and inconsistent enforcement, and securing ongoing funding for biosecurity programs, we call for actionable strategies to reduce risk while advancing safe, secure, and transformative biotechnological breakthroughs in the life sciences and strengthening national security.

Fields of Study & Subjects

Bacillus and Francisella bacterial research Viral Infections and Outbreaks Research Law AI and Intellectual Property

Publication details

Journal / source
Health Security
Publisher
SAGE Publications
Volume
24
Issue
3
Pages
278–284
Publication date
1 June 2026
Language
EN